Investigators at a tertiary clinic in India hypothesized that patients with glaucoma are in a state of chronic stress, potentially leading to “allostatic overload,” or physiologic consequences of exposure to chronic environmental stressors. Source: AAO
The AGS 2024 symposium “AI in Glaucoma: What’s Real, What’s Possible, and What’s Science Fiction” explored the current status of artificial intelligence (AI) for glaucoma and visions for its future use. Source: AAO
A pilot program for remote diagnosis of central retinal artery occlusion (CRAO) appears to facilitate the rapid diagnosis and treatment of this emergency medical condition. Source: AAO
Eye injuries due to electric scooters and hoverboards have increased dramatically, cataract surgery patients appreciate postsurgical phone calls, and sociodemographic factors may be behind the rates of uncorrected refractive error in African Americans. Source: AAO
Patients who have corneal refractive surgery and then undergo cataract surgery present unique challenges for the surgeon, particularly regarding expectations of postoperative visual acuity. Source: AAO
Dr. Felipe Medeiros discussed how intensive clustered glaucoma testing could have the potential to detect rapid glaucoma progression within a short time interval, in his talk at the AGS 2024 annual meeting. Source: AAO
Three genetic duplications seen in patients with exotropia also appear to occur at the same prevalence rates in those with esotropia, increasing the risk of developing either condition. Source: AAO
The use of telehealth by glaucoma specialists was the focus of the symposium “Dipping Your Toes from a Distance: Telehealth in Glaucoma,” held at the 2024 American Glaucoma Society meeting. Source: AAO
In the 3 months following valved tube shunt surgery, some patients may experience a dramatic rise in IOP, otherwise known as the hypertensive phase (HP). Aqueous suppressant therapy soon after surgery may reduce the incidence of HP and improve surgical outcomes. Source: AAO
James D. Brandt, MD, delivered this year’s AGS Lecture on the growing issues of overdiagnosis and overtreatment in glaucoma at the 2024 American Glaucoma Society annual meeting. Source: AAO